-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: keymaster@town.hall.org
Originator-Key-Asymmetric:
 MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq
 pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ==
MIC-Info: RSA-MD5,RSA,
 B1RDJPxcyKvIw+np9k7EN8aFr3iOzTa1DKEN6TCBrcVTv41cHJN8WhyuH+P3puXT
 AHiiL1MxAPjqxUI0MrBEuQ==

<IMS-DOCUMENT>0000898430-95-001336.txt : 19950731
<IMS-HEADER>0000898430-95-001336.hdr.sgml : 19950731
ACCESSION NUMBER:		0000898430-95-001336
CONFORMED SUBMISSION TYPE:	10-C
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	19950719
FILED AS OF DATE:		19950728
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-C
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		95556971

	BUSINESS ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217
		BUSINESS PHONE:		5032833911

	MAIL ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</IMS-HEADER>
<DOCUMENT>
<TYPE>10-C
<SEQUENCE>1
<DESCRIPTION>FORM 10-C DATED 07/19/95
<TEXT>

<PAGE>
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC  20549

                                   FORM 10-C

                    REPORT BY ISSUER OF SECURITIES QUOTED ON
                      NASDAQ INTERDEALER QUOTATION SYSTEM
                     FILED PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
                      AND RULE 13A-17 OR 15D-17 THEREUNDER


                           OXIS INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
                (EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER)

          6040 N. CUTTER CIRCLE, SUITE 317, PORTLAND, OR. 97217-3935
- --------------------------------------------------------------------------------
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

Issuer's telephone number, including area code               (503) 283-3911
                                                             --------------

                   I.  CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:

1.   Title of security                   Common Stock
                      ---------------------------------------------------------
 
2.   Number of shares outstanding before the change        10,683,687
                                                    ---------------------------
 
3.   Number of shares outstanding after the change         12,124,423
                                                    ---------------------------
 
4.   Effective date of change            July 19, 1995
                              -------------------------------------------------
 
5.   Method of change:  Specify method (such as merger, acquisition, exchange, 
     distribution, stock split, reverse split, acquisition of stock for 
     treasury, etc.)

                                    Merger
- ------------------------------------------------------------------------------

Give brief description of transaction:  On July 19, 1995, Therox
                                        ------------------------
Pharmaceuticals, Inc. ("Therox") was merged with and into OXIS Acquisition
- --------------------------------------------------------------------------
Corporation ("OXISub"), a wholly-owned subsidiary of Issuer with OXISub as the
- ------------------------------------------------------------------------------
surviving corporation.  An aggregate of 1,440,736 shares of Issuer's Common
- ---------------------------------------------------------------------------
Stock was issued in exchange for all of the outstanding shares of Therox stock.
- -------------------------------------------------------------------------------

Date:  July 26, 1995                             /s/  Ray R. Rogers
                                                ----------------------------
                                                 Ray R. Rogers
                                                 Chairman of the Board, 
                                                 OXIS International, Inc.

</TEXT>
</DOCUMENT>
</IMS-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
